Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020).

BACKGROUND: Lipoprotein metabolism disorders (LMDs) contribute to residual cardiovascular risk following acute myocardial infarction (AMI), yet population-level mortality trends remain poorly defined. OBJECTIVE: To evaluate AMI-related mortality trends among U.S. adults with LMDs from 1999-2020. METHODS: A retrospective analysis of CDC WONDER data identified decedents aged ≥25 years with LMDs (ICD-10: E78) contributing to AMI (I21) as underlying cause. Age-adjusted mortality rates (AAMR) per 100,000 were analyzed using joinpoint regression, stratified by demographics. RESULTS: Among 95,222 deaths, overall AAMR rose from 3.27 (1999) to 4.91 (2020). Three phases emerged: increase (1999-2004; APC: 6.19), stability (2004-2018; APC: -0.39), and resurgence (2018-2020; APC: 6.82). Men had higher AAMR than women (2.88 vs. 1.31). Non-Hispanic Whites (2.1) and Blacks (2.04) showed highest rates; Asians/Pacific Islanders lowest (1.39). Older adults (65-85+ years) bore greatest burden (AAMR: 9.69). Geographically, Midwest (2.33) and West (2.22) exceeded South (1.88) and Northeast (1.77). Non-metropolitan areas had markedly higher AAMR than metropolitan areas (9.08 vs. 2.37). Most deaths occurred in medical facilities (54.65%) versus home (36.71%). CONCLUSION: AMI-related mortality among U.S. adults with LMDs increased over two decades, with a concerning resurgence from 2018-2020 coinciding with the COVID-19 pandemic. Persistent disparities by sex, race, age, geography, and urbanization highlight urgent needs for targeted lipid management and equitable healthcare access to reduce cardiovascular mortality in this high-risk population.

Authors

Institutions

Publication Details

Journal
Vascular Biology
Published
2026-11-17
DOI
https://doi.org/10.1530/vb-25-0005
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020).

Javed Iqbal, Nazeer Mustafa, Aisha Mubeen, Amama Arshad
6 links
Vascular Biology
Lipoproteins and Cardiovascular Health
article

Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020).

Javed Iqbal, Nazeer Mustafa, Aisha Mubeen, Amama Arshad
article en

Abstract

BACKGROUND: Lipoprotein metabolism disorders (LMDs) contribute to residual cardiovascular risk following acute myocardial infarction (AMI), yet population-level mortality trends remain poorly defined. OBJECTIVE: To evaluate AMI-related mortality trends among U.S. adults with LMDs from 1999-2020. METHODS: A retrospective analysis of CDC WONDER data identified decedents aged ≥25 years with LMDs (ICD-10: E78) contributing to AMI (I21) as underlying cause. Age-adjusted mortality rates (AAMR) per 100,000 were analyzed using joinpoint regression, stratified by demographics. RESULTS: Among 95,222 deaths, overall AAMR rose from 3.27 (1999) to 4.91 (2020). Three phases emerged: increase (1999-2004; APC: 6.19), stability (2004-2018; APC: -0.39), and resurgence (2018-2020; APC: 6.82). Men had higher AAMR than women (2.88 vs. 1.31). Non-Hispanic Whites (2.1) and Blacks (2.04) showed highest rates; Asians/Pacific Islanders lowest (1.39). Older adults (65-85+ years) bore greatest burden (AAMR: 9.69). Geographically, Midwest (2.33) and West (2.22) exceeded South (1.88) and Northeast (1.77). Non-metropolitan areas had markedly higher AAMR than metropolitan areas (9.08 vs. 2.37). Most deaths occurred in medical facilities (54.65%) versus home (36.71%). CONCLUSION: AMI-related mortality among U.S. adults with LMDs increased over two decades, with a concerning resurgence from 2018-2020 coinciding with the COVID-19 pandemic. Persistent disparities by sex, race, age, geography, and urbanization highlight urgent needs for targeted lipid management and equitable healthcare access to reduce cardiovascular mortality in this high-risk population.

Vascular Biology
Jinnah Sindh Medical University (PK), Dow University of Health Sciences (PK)
Good health and well-being, Reduced inequalities
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon